Literature DB >> 11848480

Hypercalcemic-type of small cell carcinoma of the ovary: characterization of a new tumor line.

H Walt1, R Hornung, D Fink, D Dobler-Girdziunaite, T Stallmach, M A Spycher, F Maly, U Haller, N Bürki.   

Abstract

BACKGROUND: The aim of this study was to develop and characterize a mouse xenograft model for the hypercalcemic-type of small cell carcinoma of the ovary (HTSCCO). PATIENTS AND METHODS: Tumor fragments were removed from a patient and cultured in six subsequent generations of nude mice. Histology, comparative genomic hybridization (CGH), electron microscopy and serum calcium levels were investigated.
RESULTS: Morphology remained the same from the primary tumor of the patient through the 6th passage in the mouse. Serum calcium levels were significantly higher in the tumor-bearing mice compared to controls. CGH of the HTSCCO did not show evidence of a close relationship to either a germ cell tumor or an epithelial ovarian cancer.
CONCLUSION: Some evidence was provided that the HTSCCO is an inhomogeneous tumor that is neither related to a germ cell tumor nor to an epithelial ovarian cancer, but is a distinct tumor entity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11848480

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Endocrine pathology of the ovary : in tribute to Robert E Scully, MD.

Authors:  Esther Oliva; Robert H Young
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

2.  The promise and challenge of ovarian cancer models.

Authors:  Noor Hasan; Anders W Ohman; Daniela M Dinulescu
Journal:  Transl Cancer Res       Date:  2015-02       Impact factor: 1.241

3.  Establishment and characterization of a human ovarian small cell carcinoma, hypercalcemic type, cell line (OS-1) secreting PTH, PthrP and ACTH--special reference to the susceptibility of anti-cancer drugs.

Authors:  Satoshi Ohi; Shigeki Niimi; Naoya Okada; Kyosuke Yamada; Toshiaki Tachibana; Hisashi Hashimoto; Masako Nakajima; Mitsuru Yasuda; Tadao Tanaka; Kahei Sato; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2004-12       Impact factor: 4.174

4.  Small Cell Ovarian Carcinomas - Characterisation of Two Rare Tumor Entities.

Authors:  K Münstedt; R Estel; T Dreyer; A Kurata; A Benz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-07       Impact factor: 2.915

5.  Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.

Authors:  Lisa F Gamwell; Karen Gambaro; Maria Merziotis; Colleen Crane; Suzanna L Arcand; Valerie Bourada; Christopher Davis; Jeremy A Squire; David G Huntsman; Patricia N Tonin; Barbara C Vanderhyden
Journal:  Orphanet J Rare Dis       Date:  2013-02-21       Impact factor: 4.123

6.  c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.

Authors:  Anna Otte; Finn Rauprich; Juliane von der Ohe; Yuanyuan Yang; Friedrich Kommoss; Friedrich Feuerhake; Peter Hillemanns; Ralf Hass
Journal:  Oncotarget       Date:  2015-10-13

Review 7.  Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review.

Authors:  Lei Yin; Jianning Li; Yunhai Wei; Dejian Ma; Yamei Sun; Yanlai Sun
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

8.  Small cell carcinoma of the ovary of hypercalcemic type: a case report.

Authors:  S Zaied; O Gharbi; A Zayène; R Rjiba; R Hadhri; A Hadded; M Hochlef; L Ben Fatma; S Ben Ahmed
Journal:  Case Rep Oncol Med       Date:  2012-12-30

9.  In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model.

Authors:  Anna Otte; Finn Rauprich; Peter Hillemanns; Tjoung-Won Park-Simon; Juliane von der Ohe; Ralf Hass
Journal:  Orphanet J Rare Dis       Date:  2014-08-08       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.